Literature DB >> 26542707

The role of prolactin in andrology: what is new?

Giulia Rastrelli1, Giovanni Corona1,2, Mario Maggi3.   

Abstract

Prolactin (PRL) has been long deemed as a hormone involved only in female reproduction. However, PRL is a surprising hormone and, since its identification in the 1970s, its attributed functions have greatly increased. However, its specific role in male health is still widely unknown. Recently, low PRL has been associated with reduced ejaculate and seminal vesicle volume in infertile subjects. In addition, in men consulting for sexual dysfunction, hypoprolactinemia has been associated with erectile dysfunction and premature ejaculation, findings further confirmed in the general European population and infertile men. Several metabolic derangements, recapitulating metabolic syndrome, have also been associated with low PRL both in men with sexual dysfunction and from the general European population. In men with sexual dysfunction, followed-up for more than 4 years, low PRL was identified as an independent predictor of the incidence of major adverse cardiovascular events. Finally, an association with anxiety or depressive symptoms has been found in men with sexual dysfunction and from the general European population. While a direct role for impaired PRL function in the pathogenesis of these reproductive, sexual, metabolic and psychological disorders is conceivable, the possibility that low PRL is a mirror of an increased dopaminergic or a decreased serotonergic tone cannot be ruled-out. Hyperactivity of the dopaminergic system can explain only a few of the aforementioned findings, whereas a hypo-serotonergic tone fits well with the clinical features associated with low PRL, and there is significant evidence supporting the hypothesis that PRL could be a mirror of serotonin in the brain.

Entities:  

Keywords:  Man; Metabolism; Prolactin; Serotonin; Sexuality

Mesh:

Substances:

Year:  2015        PMID: 26542707     DOI: 10.1007/s11154-015-9322-3

Source DB:  PubMed          Journal:  Rev Endocr Metab Disord        ISSN: 1389-9155            Impact factor:   6.514


  230 in total

1.  Hyperphagia and increased growth in rats after intraventricular injection of 5,7-dihydroxytryptamine.

Authors:  C F Saller; E M Stricker
Journal:  Science       Date:  1976-04-23       Impact factor: 47.728

2.  Combination of a GnRH agonist with an antiandrogen or bromocriptine in the treatment of prostatic cancer; slight potentiation of antigonadal effects.

Authors:  I Huhtaniemi; M Parvinen; P Venho; S Rannikko
Journal:  Int J Androl       Date:  1991-10

3.  Prolactin-screening tumors and hypogonadism in 22 men.

Authors:  J N Carter; J E Tyson; G Tolis; S Van Vliet; C Faiman; H G Friesen
Journal:  N Engl J Med       Date:  1978-10-19       Impact factor: 91.245

4.  A receptor-mediated mechanism for the transport of prolactin from blood to cerebrospinal fluid.

Authors:  R J Walsh; F J Slaby; B I Posner
Journal:  Endocrinology       Date:  1987-05       Impact factor: 4.736

5.  Sex-specific associations of serum prolactin concentrations with cardiac remodeling: longitudinal results from the Study of Health Pomerania (SHIP).

Authors:  Robin Haring; Henry Völzke; Ramachandran S Vasan; Stephan B Felix; Matthias Nauck; Marcus Dörr; Henri Wallaschofski
Journal:  Atherosclerosis       Date:  2012-01-13       Impact factor: 5.162

6.  Serum prolactin concentrations determine whether they improve or impair β-cell function and insulin sensitivity in diabetic rats.

Authors:  Sunmin Park; Da Sol Kim; James W Daily; Sung-Hoon Kim
Journal:  Diabetes Metab Res Rev       Date:  2011-09       Impact factor: 4.876

7.  A synergistic effect of serotonin transporter gene polymorphism and smoking in association with CHD.

Authors:  T Arinami; T Ohtsuki; K Yamakawa-Kobayashi; H Amemiya; H Fujiwara; K Kawata; H Ishiguro; H Hamaguchi
Journal:  Thromb Haemost       Date:  1999-06       Impact factor: 5.249

Review 8.  Hormonal causes of male sexual dysfunctions and their management (hyperprolactinemia, thyroid disorders, GH disorders, and DHEA).

Authors:  Mario Maggi; Jaques Buvat; Giovanni Corona; André Guay; Luiz Otavio Torres
Journal:  J Sex Med       Date:  2012-04-23       Impact factor: 3.802

9.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

10.  Effects of deletion of the prolactin receptor on ovarian gene expression.

Authors:  Isabelle Grosdemouge; Anne Bachelot; Aurélie Lucas; Nathalie Baran; Paul A Kelly; Nadine Binart
Journal:  Reprod Biol Endocrinol       Date:  2003-02-06       Impact factor: 5.211

View more
  13 in total

1.  The relevance of ANXA5 genetic variants on male fertility.

Authors:  Heloisa Lopes Lavorato; Arseni Markoff; Valeria Altholz; Nadja Bogdanova; Peter Wieacker; Sabine Kliesch; Stefan Schlatt
Journal:  J Assist Reprod Genet       Date:  2019-06-13       Impact factor: 3.412

Review 2.  Prolactin Biology and Laboratory Measurement: An Update on Physiology and Current Analytical Issues.

Authors:  Mohamed Saleem; Helen Martin; Penelope Coates
Journal:  Clin Biochem Rev       Date:  2018-02

3.  Waterpipe Tobacco Smoke Exposure during Lactation-Susceptibility of Reproductive Hormones and Oxidative Stress Parameters in Male Progeny Rats.

Authors:  Nour A Al-Sawalha; Indira D Pokkunuri; Karem H Alzoubi; Omar F Khabour; Bashar N Almomani
Journal:  Reprod Sci       Date:  2020-08-03       Impact factor: 3.060

Review 4.  Prostatic irradiation-induced sexual dysfunction: A review and multidisciplinary guide to management in the radical radiotherapy era (Part III on Psychosexual Therapy and the Masculine Self-Esteem).

Authors:  Marigdalia K Ramirez-Fort; Paula Suarez; Margely Carrion; Daniel Weiner; Claire Postl; Ricardo Arribas; Mehdi Sayyah; Digna V Forta; M Junaid Niaz; Amir Feily; Christopher S Lange; Zhahedia Zhaythseff Fort; Migdalia Fort
Journal:  Rep Pract Oncol Radiother       Date:  2020-04-30

5.  Erectile dysfunction as a marker of endocrine and glycemic disorders.

Authors:  R Mazzilli; V Zamponi; S Olana; N Mikovic; D Cimadomo; G Defeudis; A Faggiano
Journal:  J Endocrinol Invest       Date:  2022-04-02       Impact factor: 5.467

Review 6.  Erectile dysfunction in fit and healthy young men: psychological or pathological?

Authors:  Giulia Rastrelli; Mario Maggi
Journal:  Transl Androl Urol       Date:  2017-02

Review 7.  Frontiers in hormone therapy for male infertility.

Authors:  Iyad Khourdaji; Haerin Lee; Ryan P Smith
Journal:  Transl Androl Urol       Date:  2018-07

Review 8.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

9.  Assessment of hormonal activity in patients with premature ejaculation.

Authors:  Lutfi Canat; Akif Erbin; Masum Canat; Mehmet Dinek; Turhan Caskurlu
Journal:  Int Braz J Urol       Date:  2017 Mar-Apr       Impact factor: 1.541

10.  Longer trinucleotide repeats of androgen receptor are associated with higher testosterone and low oxytocin levels in diabetic premature ejaculatory dysfunction patients.

Authors:  Haroon Latif Khan; Shahzad Bhatti; Sana Abbas; Yousaf Latif Khan; Rosa Maria Marquez Gonzalez; Muhammad Aslamkhan; Gerardo Rodriguez Gonzalez; Hikmet Hakan Aydin
Journal:  Basic Clin Androl       Date:  2018-03-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.